Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$997K Buy
12,011
+7,885
+191% +$675K ﹤0.01% 1287
2025
Q4
$353K Buy
+4,126
New +$345K ﹤0.01% 1604
2025
Q3
Sell
-3,169
Closed -$338K 1613
2025
Q2
$338K Sell
3,169
-462
-13% -$47.1K ﹤0.01% 1471
2025
Q1
$348K Sell
3,631
-981
-21% -$102K ﹤0.01% 1572
2024
Q4
$506K Sell
4,612
-6,568
-59% -$764K ﹤0.01% 1563
2024
Q3
$1.52M Buy
11,180
+1,786
+19% +$244K ﹤0.01% 1207
2024
Q2
$1.39M Sell
9,394
-1,898
-17% -$266K ﹤0.01% 1166
2024
Q1
$1.37M Buy
11,292
+1,053
+10% +$120K ﹤0.01% 1232
2023
Q4
$1.03M Sell
10,239
-169,214
-94% -$15.6M ﹤0.01% 1321
2023
Q3
$14.8M Buy
179,453
+56,158
+46% +$5.77M 0.01% 756
2023
Q2
$14.4M Buy
123,295
+22,198
+22% +$2.65M 0.01% 767
2023
Q1
$12.5M Buy
101,097
+95,960
+1,868% +$11.6M 0.01% 797
2022
Q4
$629K Sell
5,137
-756
-13% -$66.9K ﹤0.01% 1366
2022
Q3
$467K Buy
5,893
+2,592
+79% +$180K ﹤0.01% 1344
2022
Q2
$174K Hold
3,301
﹤0.01% 1378
2022
Q1
$238K Sell
3,301
-486
-13% -$46K ﹤0.01% 1369
2021
Q4
$477K Hold
3,787
﹤0.01% 1398
2021
Q3
$543K Hold
3,787
﹤0.01% 1348
2021
Q2
$441K Buy
+3,787
New +$373K ﹤0.01% 1286

Other funds holding CROX

Amundi's CROX Position: Q1 2026 in Review

Amundi increased its Crocs (CROX) stake by 191% in Q1 2026, buying an estimated $675K and bringing the position to 12,011 shares worth $997K. The position accounts for ﹤0.01% of the portfolio, ranked #1287.

Amundi first reported a position in CROX in Q2 2021 and has held it in 19 quarters since. The position peaked at $14.8M in Q3 2023. 456 funds tracked by Wall St. Rank hold CROX as of Q1 2026.

  • Amundi held 12,011 shares of Crocs worth $997K as of Q1 2026.
  • Amundi bought 7,885 Crocs shares in Q1 2026, an estimated $675K.
  • Crocs made up ﹤0.01% of Amundi's portfolio in Q1 2026, its #1287 holding.
  • Amundi first reported a position in Crocs in Q2 2021 and has held it in 19 quarters since.
  • Amundi's Crocs position peaked at $14.8M in Q3 2023.
  • 456 funds tracked by Wall St. Rank held Crocs as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.